Citation Impact
Citing Papers
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
2007 StandoutNobel
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Destabilization of the complete protein secondary structure on binding to the chaperone GroEL
1994 StandoutNatureNobel
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
An Olfactory Sensory Map in the Fly Brain
2000 StandoutNobel
Small‐Molecule Affinity Ligands for Protein Purification: Combined Computational Enrichment and Automated In‐line Screening of an Optically Encoded Library
2010 StandoutNobel
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Stereoselective synthesis of 2,4,5-trisubstituted piperidines by carbonyl ene and Prins cyclisations
2008
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
Signal Transduction by GABAB Receptor Heterodimers
2000
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
2013
Nonresolving Inflammation
2010 Standout
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy
1991 StandoutNatureNobel
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
2004
Click Chemistry: Diverse Chemical Function from a Few Good Reactions
2001 StandoutNobel
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
2010 StandoutNature
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
2005
Origin and physiological roles of inflammation
2008 StandoutNature
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
1992 StandoutNature
Transforming Growth Factor β in Tissue Fibrosis
1994 Standout
Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes
2002 StandoutNobel
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
1991 Standout
Comprehensive survey of chemical libraries yielding enzyme inhibitors, receptor agonists and antagonists, and other biologically active agents: 1992 through 1997
1997
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2
1998 Nature
PREDICT modeling and in‐silico screening for G‐protein coupled receptors
2004
Toward high-resolution prediction and design of transmembrane helical protein structures
2007 StandoutNobel
In Vitro Approaches to the Mechanism of Cell-Mediated Immune Reactions
1971
Multiple sclerosis: An immunologic reassessment
1973
Production of Macrophage Migration Inhibition Factors by Virus-Infected Cell Cultures
1973 StandoutNobel
Characterization of cloned cDNA representing rat myelin basic protein: Absence of expression in brain of shiverer mutant mice
1983 StandoutNobel
Fluorine in medicinal chemistry
2007 Standout
PRODUCTION OF MACROPHAGE MIGRATION INHIBITION FACTOR BY CONTINUOUS CELL LINES
1972
Cell Surveillance Model for Lymphocyte Cooperation
1971 Nature
Acyclic NK-1 antagonists: 2-benzhydryl-2-aminoethyl ethers
1994
Polymyositis and Dermatomyositis
1975 Standout
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
1999 StandoutScience
IMMUNOLOGICAL TOLERANCE IN BONE MARROW-DERIVED LYMPHOCYTES
1974 StandoutNobel
The asymmetric synthesis of aziridines
1997
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Styrylsulfonates and ‐Sulfonamides through Pd‐Catalysed Matsuda–Heck Reactions of Vinylsulfonic Acid Derivatives and Arenediazonium Salts
2016
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system
1974 StandoutNatureNobel
CYTOTOXIC THYMUS-DERIVED LYMPHOCYTES IN CEREBROSPINAL FLUID OF MICE WITH LYMPHOCYTIC CHORIOMENINGITIS
1973 StandoutNobel
Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
1971
Phenyl-glycinol based NK1 receptor antagonists — towards the minimum pharmacophore
1995
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
1991 StandoutScience
Problems encountered in the preparation of migration inhibitory factor (MIF) and mitogenic factor (MIT) from phytomitogen-stimulated human peripheral lymphocytes and in the preparation of MIF from human lymphoid cell lines (LCL)
1975
Lymphotoxin ? An immunologic hormone with anticarcinogenic and antitumor activity
1982
Strategien zur Modulation von Protein‐Protein‐Wechselwirkungen mit synthetischen Substanzen
2005
Human Macrophage Migration Inhibition Factor: Evidence for Subunit Structure
1979 StandoutScienceNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
The Cutaneous Infiltrates of Leprosy
1982 StandoutNobel
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
1986
Cytokines in context.
1991
Serum Migration-Inhibitory Activity in Patients with Lymphoproliferative Diseases
1974 StandoutNobel
Polymyositis and Dermatomyositis
1975 Standout
Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
1984 Science
Click Chemistry: Diverse Chemical Function from a Few Good Reactions
2001 StandoutNobel
Chemical and Pharmacological Research of the Plants in Genus Euphorbia
2008 Standout
An analysis of in vitro T cell responsiveness in lepromatous leprosy.
1985 StandoutNobel
Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
1985 StandoutScience
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
The macrophage disappearance reaction
1972 StandoutNobel
Confined Acid-Catalyzed Asymmetric Carbonyl–Ene Cyclization
2015 StandoutNobel
Bromine-Catalyzed Aziridination of Olefins. A Rare Example of Atom-Transfer Redox Catalysis by a Main Group Element
1998 StandoutNobel
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
Allosteric activation of the CaR by l -amino acids
2000 StandoutNobel
Lymphotoxin formation by lymphocytes and muscle in polymyositis
1972
GENETIC CONTROL OF THYMUS-DERIVED CELL FUNCTION
1972 StandoutNobel
STUDIES ON CELL-MEDIATED IMMUNITY TO LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN MICE
1973
THE PRODUCTION OF MIGRATION INHIBITION FACTOR BY B AND T CELLS OF THE GUINEA PIG
1973 StandoutNobel
IN VITRO AND IN VIVO ACTIVITY OF A LYMPHOCYTE AND IMMUNE COMPLEX-DEPENDENT CHEMOTACTIC FACTOR FOR EOSINOPHILS
1971 StandoutNobel
Receptor-Induced Conformation Change of the Immunosuppressant Cyclosporin A
1991 StandoutScienceNobel
Interaction between “sensitized lymphocytes” and antigen in vitro
1970
The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor
1970
Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
1975 StandoutNobel
Works of William Howson being referenced
Electrophysiological characterization of potent agonists and antagonists at pre‐ and postsynaptic GABAB receptors on neurones in rat brain slices
1990
Rational design of high affinity tachykinin NK1 receptor antagonists
1994
The design of dipeptide helical mimetics: The synthesis, tachykinin receptor affinity and conformational analysis of 1,1,6-trisubstituted indanes
1996
Rational design of high affinity tachykinin NK2 receptor antagonists
1994
The effects of adenosine triphosphate and related purines on arterial resistance vessels in vitro and in vivo
1989
The design of a dipeptide library for screening at peptide receptor sites
1993
An SAR study for the non-peptide substance P receptor (NK1) antagonist, CP-96,345.
1992
Synthèse et évaluation biologique d'analogues de l'ATP agissant sur les récepteurs supposés purinérgiques P2X dans la vessie de cobaye
1988
The rational development of small molecule tachykinin NK3 receptor selective antagonists - the utilisation of a dipeptide chemical library in drug design
1994
IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN A
1981
Direct preparation of N-diphenylphosphinoyl aziridines from 1,2-aminoalcohols utilizing nucleofugacity of diphenylphosphinates
1994
“Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte Activation
1969 Nature
Synthesis of (±)-3-Amino-2-(4-chlorophenyl)propanesulfonic acid (Saclofen)
1991
Ring-opening of N-tosyl aziridines by 2-lithiodithianes
1995